Buy, hold, or sell? Bubs, Soul Patts, and Endeavour shares

S&P/ASX 200 Index (ASX: XJO) shares are down 0.07% to 8,945.5 points on Thursday.

Meantime, brokers have reviewed their ratings and 12-month share price targets on three ASX shares.

Bubs Australia Ltd (ASX: BUB)

The Bubs share price is steady at 11 cents, and down 12.5% over 12 months.

This week, Shaw & Partners gave the ASX consumer staples share a buy rating.

The broker said its DCF valuation remained 18 cents per share following the company’s 2026 Strategy Day.

We are particularly impressed by BUB’s success in the USA.

Having only entered the USA in 2022 under the FDA’s enforcement discretion, US distribution is expected to reach circa 10,000 doors by end 2026, up over 100% on 2025.

Given that Kendamil only recently received permanent FDA approval, we expect BUB’s permanent approval to come through shortly. 

BUB re-iterated its FY26 guidance for Revenue of $120-125m and reported EBITDA of $4- 6m.

Our forecasts remain $121.5m and $4.5m, respectively.

Washington H. Soul Pattinson and Co Ltd (ASX: SOL)

Soul Patts shares are $43.26, up 0.7% today, and up 23.8% over 12 months.

Morgans maintains a hold rating on this ASX financial share following its 1H FY26 report.

The diversified investment group reported statutory net profit after tax (NPAT) of $2,303 million, up 604.3%.

The extraordinary increase reflected the Brickworks merger, the sell-down of Tuas Ltd (ASX: TUA) and Aeris Resources Ltd (ASX: AIS) shares, and a realised gain from the sale of Apex Healthcare.

Underlying regular NPAT increased 6.7% to $304 million.

The pre-tax net asset value (NAV) climbed 14.6% to $13.8 billion, and the portfolio generated a 9.7% return for the first half.

Soul Patts increased its interim dividend by 9.1% to 48 cents per share, fully franked.

Morgans commented:

We continue to like the SOL story, particularly its track record of growing distributions and history of uncorrelated and above market returns.

Endeavour Group Ltd (ASX: EDV)

Endeavour shares are $3.28, down 0.2% today, and down 16.2% over 12 months.

The Endeavour share price fell to a record low of $3.13 on Tuesday.

On The Bull this week, Mark Elzayed from Investor Pulse revealed a sell rating on Endeavour shares.

In our view, key concerns emerged in its first half result in fiscal year 2026.

Underlying group earnings before interest and tax of $563 million fell 5.4 per cent despite a 0.9 per cent increase in group sales to $6.7 billion.

While the hotels segment generated a 4.4 per cent increase in sales, the retail division, comprising Dan Murphy’s and BWS, posted a 11.6 per cent decline in underlying EBIT.

Statutory net profit after tax fell 17.1 per cent to $247 million, impacted by $45 million in significant items.

Downward revisions in consensus earnings per share suggest the bottom may not have been reached at this point.

The post Buy, hold, or sell? Bubs, Soul Patts, and Endeavour shares appeared first on The Motley Fool Australia.

More reading

• Which of these ASX stocks near 52-week lows is worth buying?
• Why I invest a lot in ASX shares outside of superannuation
• Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares
• Forget term deposits! I’d buy these ASX dividend shares instead!
• What is Morgans saying about these massively popular ASX 200 stocks?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.